Scaffold/Extracellular matrix hybrid constructs for bone-tissue engineering.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23184883.
- Also identified by DOI 10.1002/adhm.201200209 and PMC identifier 3551448.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The limited natural ability of the body to fully repair large bone defects often necessitates the implantation of a replacement material to promote healing. While the current clinical strategies to address such bone defects generally carry associated limitations, bone-tissue engineering approaches seek to minimize any adverse effects and facilitate complete regeneration of the lost tissue. Of particular interest are hybrid constructs that incorporate multiple components found within the native bone matrix to enhance the osteogenicity of biocompatible materials, which might otherwise be non-osteogenic. This Progress Report will focus on such hybrid constructs that incorporate multiple components from native bone matrix for bone-tissue engineering and will highlight the synthesis and characterization of the hybrid constructs, cellular attachment and proliferation within the constructs, in vitro osteogenicity of the constructs, and the biological response to in vivo implantation of the constructs at ectopic and orthotopic sites.
Medical subject headings
- Bone Development
- Bone Substitutes
- Extracellular Matrix
- Tissue Engineering
- Tissue Scaffolds